Why the study?
Does 6-Amino-9-D-psicofuranosylpurine cause acute pericarditis?
Does 6-Amino-9-D-psicofuranosylpurine cause acute pericarditis?
This report identifies acute pericarditis as a potential toxic manifestation of 6-Amino-9-D-psicofuranosylpurine therapy.
Answers are grounded in this paper and cite their sources.
Clinicians should monitor for pericarditis during 6-Amino-9-D-psicofuranosylpurine therapy; case reports leave causality and incidence open.
THE purpose of this communication is to describe 3 cases of acute pericarditis as toxic manifestations of drug therapy.6-Amino-9-D-psicofuranosylpurine,§ an antibiotic originally described by Eble and his associates,1 is produced by a strain of actinomycete tentatively identified as Streptomyces hygroscopicus, var. decoyicus. It was found to be active2 , 3 against Staphy- lococcus aureus, Streptococcus haemolyticus and some strains of Escherichia coli in mice. It was almost inactive when tested in vitro. In addition to these properties the drug was found to have antitumor activity4 in several types of animal tumors, including Walker adenocarcinomas, Jensen sarcomas, Murphy—Sturm lymphosarcomas and Guerin tumors . . .
No takes yet. Share an insight, caveat, or question.
Yates et al. (1961) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: